Vulnerability of β-Thalassemia Heterozygotes to COVID-19: Results from a Cohort Study.
Sotiriou S, Samara AA, Lachanas KE, Vamvakopoulou D, Vamvakopoulos KO, Vamvakopoulos N, Janho MB, Perivoliotis K, Donoudis C, Daponte A, Gourgoulianis KI, Boutlas S.
Sotiriou S, et al.
J Pers Med. 2022 Feb 25;12(3):352. doi: 10.3390/jpm12030352.
J Pers Med. 2022.
PMID: 35330352
Free PMC article.